Unknown

Dataset Information

0

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.

ABSTRACT: The causative agent of coronavirus disease 2019 (COVID-19) is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For many viruses, tissue tropism is determined by the availability of virus receptors and entry cofactors on the surface of host cells. In this study, we found that neuropilin-1 (NRP1), known to bind furin-cleaved substrates, significantly potentiates SARS-CoV-2 infectivity, an effect blocked by a monoclonal blocking antibody against NRP1. A SARS-CoV-2 mutant with an altered furin cleavage site did not depend on NRP1 for infectivity. Pathological analysis of olfactory epithelium obtained from human COVID-19 autopsies revealed that SARS-CoV-2 infected NRP1-positive cells facing the nasal cavity. Our data provide insight into SARS-CoV-2 cell infectivity and define a potential target for antiviral intervention.

SUBMITTER: Cantuti-Castelvetri L 

PROVIDER: S-EPMC7857391 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The causative agent of coronavirus disease 2019 (COVID-19) is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For many viruses, tissue tropism is determined by the availability of virus receptors and entry cofactors on the surface of host cells. In this study, we found that neuropilin-1 (NRP1), known to bind furin-cleaved substrates, significantly potentiates SARS-CoV-2 infectivity, an effect blocked by a monoclonal blocking antibody against NRP1. A SARS-CoV-2 mutant with an al  ...[more]

Similar Datasets

Unknown Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-1.
| S-EPMC9721373 | biostudies-literature
Unknown Integrin αvβ1 facilitates ACE2-mediated entry of SARS-CoV-2.
| S-EPMC10651773 | biostudies-literature
Unknown Cell entry by SARS-CoV-2.
| S-EPMC8180548 | biostudies-literature
Unknown Novel Compounds Targeting Neuropilin Receptor 1 with Potential To Interfere with SARS-CoV-2 Virus Entry.
| S-EPMC8029449 | biostudies-literature
Unknown ADAM10 and ADAM17 promote SARS-CoV-2 cell entry and spike protein-mediated lung cell fusion
| S-SCDT-EMBOR-2021-54305V1 | biostudies-other
Unknown Cell entry mechanisms of SARS-CoV-2.
| S-EPMC7260975 | biostudies-literature
Unknown Mutations Strengthened SARS-CoV-2 Infectivity.
| S-EPMC7375973 | biostudies-literature
Unknown SARS-CoV-2 cell entry beyond the ACE2 receptor.
| S-EPMC9244107 | biostudies-literature
Unknown Intermediates in SARS-CoV-2 spike-mediated cell entry.
| S-EPMC9390989 | biostudies-literature
Unknown S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review.
| S-EPMC9968219 | biostudies-literature